According to a Dec. 30 press release, the state received 5,000 courses of molnupirvar by Merck and 1,000 courses of Paxlovid by Pfizer. Both treatments are recommended for individuals who are at a higher risk for COVID-19 or for those who have underlying medical conditions.
The antiviral treatment is free, and the health department has coordinated a distribution plan with Walmart pharmacies across the state.
The Tennessee Department of Health anticipates another shipment of both antiviral treatments to arrive in the coming weeks as production increases, according to the press release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
